EUVIMEDEUVIMED entdecken
Fallbericht

Efficacy of Propranolol Combined with Different Modalities of Unilateral Adrenalectomy in a Case Series of 4 ARMC5-mutated Patients

Fan Yu, Baowen Yu, Hongwen Zhou, He Wei, Hong-Qi Fan

Experimental and Clinical Endocrinology & Diabetes · 01.05.2025 · 133 (05) · 235-245

DOI: 10.1055/a-2559-9643 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.05.2025. Verfasst von Fan Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Adrenalectomy, Adrenergic beta-Antagonists, Cushing Syndrome, Propranolol. Die Arbeit nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Specialized Research Fund for the Doctoral Program of Higher Education of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Limited research has explored the efficacy of β-blockers in combination with unilateral total, subtotal, or partial adrenalectomy in ARMC5-mutated patients with primary bilateral macronodular adrenocortical hyperplasia (PBMAH). Additionally, there is no consensus on determining the optimal side for adrenal gland resection. To assess the clinical utility of three unilateral adrenalectomy (ULA) modalities—total, subtotal, and partial—combined with β-blocker treatment in patients with PBMAH and Cushing’s syndrome (CS). This study was conducted at a single tertiary referral center involving a series of four patients with suspected CS. Diagnosis of PBMAH was confirmed through dexamethasone suppression testing, evaluation of ectopic receptor expression, and whole-exome sequencing. Three patients underwent unilateral total, subtotal, or partial adrenalectomy, respectively, while one patient declined surgery. All patients received β-blocker treatment. The median treatment duration among the four ARMC5-mutuated PBMAH patients was 30.5 months (range: 6–45 months). Two patients who underwent total or subtotal adrenalectomy on the side with more pronounced nodularity showed postoperative improvement in clinical CS signs, glycemic control, and hypertension. These two patients, along with another patient with bilateral diffuse (non-nodular) adrenal hyperplasia who declined surgery, showed further improvement in hypercortisolism and cortisol/adrenocorticotropic hormone (ACTH) ratio (CAR: plasma cortisol (nmol/L)/plasma ACTH (pg/ml), newly reported as a reliable parameter of cortisol secretory capacity in patients with adrenal CS) after propranolol treatment. The patient who underwent partial adrenalectomy on the side with less pronounced nodularity showed no significant improvement in hypercortisolism or CAR, and the response to propranolol was also unsatisfactory. All four cases harbored pathogenic variants in the ARMC gene, including two novel germline mutations. In ARMC5-mutuated patients with PBMAH, unilateral total adrenalectomy on the side with more pronounced nodularity appears to be an effective treatment option. Propranolol may be considered as an alternative or adjunctive therapy to ULA for managing hypercortisolism in those with ARMC5 mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdrenalectomyAdrenergic beta-AntagonistsCushing SyndromePropranololHumansArmadillo Domain ProteinsCombined Modality TherapyMutation

Substanzen

Adrenergic beta-AntagonistsArmadillo Domain ProteinsARMC5 protein, humanPropranolol

Autor:innen und Institutionen

  • Department of Endocrinology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
  • Department of Endocrinology, Jurong Hospital Affiliated to Jiangsu University, Zhenjiang, China.
  • Nanjing First Hospital, Nanjing, China.

Förderung

  • National Natural Science Foundation of China
  • Specialized Research Fund for the Doctoral Program of Higher Education of China

Zitieren

APA

Yu, F., Yu, B., Zhou, H., Wei, H., & Fan, H. Q. (2025). Efficacy of Propranolol Combined with Different Modalities of Unilateral Adrenalectomy in a Case Series of 4 ARMC5-mutated Patients. Experimental and Clinical Endocrinology & Diabetes, 133(05), 235-245. https://doi.org/10.1055/a-2559-9643

Vancouver

Yu F, Yu B, Zhou H, Wei H, Fan HQ. Efficacy of Propranolol Combined with Different Modalities of Unilateral Adrenalectomy in a Case Series of 4 ARMC5-mutated Patients. Experimental and Clinical Endocrinology & Diabetes. 2025;133(05):235-245. doi:10.1055/a-2559-9643

BibTeX
@article{Yu2025,
  author = {Yu, Fan and Yu, Baowen and Zhou, Hongwen and Wei, He and Fan, Hong-Qi},
  title = {Efficacy of Propranolol Combined with Different Modalities of Unilateral Adrenalectomy in a Case Series of 4 ARMC5-mutated Patients},
  journal = {Experimental and Clinical Endocrinology & Diabetes},
  year = {2025},
  volume = {133},
  number = {05},
  pages = {235--245},
  doi = {10.1055/a-2559-9643}
}
Kostenlos starten →